Zifi XL 1.5 Injection

Composition of Zifi XL 1.5 Injection

Zifi XL 1.5 Injection contains Ceftriaxone 1000 mg + Sulbactam 500 mg (as sterile powder for injection). It belongs to the Third-generation cephalosporin + Beta-lactamase inhibitor class of medicines.

Uses of Zifi XL 1.5 Injection

• Treatment of susceptible bacterial infections such as lower/upper respiratory tract infections
• urinary tract infections
• skin and soft tissue infections
• intra-abdominal infections
• gynecological infections
• bone and joint infections
• septicemia
• and meningitis (as per physician).

Key benefits

• Broad-spectrum coverage for serious infections
• Effective against beta-lactamase producing bacteria
• Suitable for IV/IM hospital use
• Helps in respiratory and urinary tract infections
• Useful in skin/soft tissue and intra-abdominal infections

How Zifi XL 1.5 Injection works

Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis leading to bacterial death. Sulbactam is a beta-lactamase inhibitor that protects ceftriaxone from degradation by beta-lactamase enzymes, helping extend activity against resistant organisms.

How to take Zifi XL 1.5 Injection

Take exactly as prescribed by your doctor.

Side effects of Zifi XL 1.5 Injection

Most side effects of Zifi XL are mild and settle as the body adjusts. Reported side effects include:

• Injection site pain/swelling
• diarrhea
• nausea
• vomiting
• rash
• headache
• dizziness
• elevated liver enzymes
• eosinophilia

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Zifi XL 1.5 Injection

Warnings and precautions

Prescription-only antibiotic; use only for confirmed/suspected bacterial infections. Contraindicated in patients with hypersensitivity to cephalosporins; use caution in penicillin allergy. Monitor for severe diarrhea/C. difficile colitis, superinfection, and hypersensitivity reactions. Use caution in severe hepatic/renal impairment; dose adjustment/monitoring may be needed. Ceftriaxone should not be mixed with calcium-containing IV solutions; avoid concurrent calcium IV administration in neonates. Prolonged use may cause altered blood counts; monitor if therapy is extended.

Do not take Zifi XL if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for anyone with a known allergy to cephalosporin antibiotics. Not for anyone with a known penicillin allergy.

Interactions with other medicines

Calcium-containing IV solutions (incompatibility/precipitation risk), warfarin/other anticoagulants (may increase bleeding risk via altered vitamin K flora), aminoglycosides/loop diuretics (potential additive nephrotoxicity—monitor), oral contraceptives (reduced efficacy possible due to gut flora alteration)

How to store Zifi XL 1.5 Injection

Store in a cool, dry place below 25°C, protected from light and moisture. Keep vial in original pack. Use reconstituted solution within the time limits specified on labeling; do not freeze unless directed in product insert.

Expert advice for Zifi XL 1.5 Injection

Space the doses evenly and complete the course. Keep the reconstituted syrup as the pharmacist instructed and discard it after the stated number of days. Space the doses evenly through the day so the level stays steady. Take a probiotic a few hours apart if loose motions trouble you, and drink plenty of fluids. Never use a leftover antibiotic, or someone else's, for a new illness.

Manufacturer and class

Manufacturer:

FDC LIMITED

Therapeutic class:

Antibiotic

Drug class:

Third-generation cephalosporin + Beta-lactamase inhibitor